Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

SHINECO Return on Tangible Equity 2016-2025 | SISI

Current and historical return on tangible equity values for SHINECO (SISI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
SHINECO Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.04B $0.01B -1114.29%
2024-12-31 $-0.03B $-0.01B 415.38%
2024-09-30 $-0.03B $-0.01B 313.51%
2024-06-30 $-0.02B $0.02B 179.59%
2024-03-31 $-0.01B $-0.03B 50.91%
2023-12-31 $-0.01B $-0.02B 560.00%
2023-09-30 $-0.01B $-0.02B -43.64%
2023-06-30 $-0.01B $0.02B -45.22%
2023-03-31 $-0.02B $0.02B -46.15%
2022-12-31 $-0.02B $0.04B -41.10%
2022-09-30 $-0.02B $0.04B -39.74%
2022-06-30 $-0.03B $0.03B -71.05%
2022-03-31 $-0.03B $0.04B -73.62%
2021-12-31 $-0.04B $0.04B -81.40%
2021-09-30 $-0.05B $0.04B -96.77%
2021-06-30 $-0.03B $0.04B -59.53%
2021-03-31 $-0.02B $0.05B -38.98%
2020-12-31 $-0.02B $0.06B -30.16%
2020-09-30 $-0.01B $0.07B -9.02%
2020-06-30 $-0.01B $0.07B -10.45%
2020-03-31 $-0.01B $0.07B -7.33%
2019-12-31 $0.00B $0.07B -2.87%
2019-09-30 $0.00B $0.07B -1.43%
2019-06-30 $0.00B $0.07B 2.84%
2019-03-31 $0.00B $0.07B -1.42%
2018-12-31 $0.01B $0.07B 7.02%
2018-09-30 $0.01B $0.07B 11.43%
2018-06-30 $0.01B $0.07B 11.64%
2018-03-31 $0.01B $0.07B 17.98%
2017-12-31 $0.01B $0.07B 14.29%
2017-09-30 $0.01B $0.07B 13.22%
2017-06-30 $0.01B $0.06B 13.73%
2017-03-31 $0.01B $0.06B 12.73%
2016-12-31 $0.01B $0.06B 17.39%
2016-09-30 $0.01B $0.06B 30.48%
2016-06-30 $0.01B $0.05B 65.31%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.002B $0.010B
Shineco, Inc. is principally engaged in the production and distribution of herbal medicines, organic agricultural produce, specialized textiles and other health and well-being focused plant-based products primarily in China. Shineco, Inc. is headquartered in Beijing, China.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.041B 27.71
Zoetis (ZTS) US $69.314B 25.15
Takeda Pharmaceutical (TAK) JP $47.697B 9.73
Daiichi Sankyo, - (DSNKY) Japan $45.256B 23.19
BeOne Medicines - (ONC) CH $33.543B 0.00
Sandoz Group AG (SDZNY) CH $27.672B 0.00
Summit Therapeutics (SMMT) US $17.605B 0.00
Merck (MKKGY) Germany $16.427B 10.68
Shionogi (SGIOY) JP $14.649B 0.00
Neurocrine Biosciences (NBIX) United States $13.846B 41.30
United Therapeutics (UTHR) US $13.747B 11.90
IPSEN (IPSEY) France $11.409B 0.00
Orion OYJ (ORINY) FI $11.203B 27.00
Madrigal Pharmaceuticals (MDGL) United States $9.722B 0.00
Eisai (ESAIY) $8.913B 10.05
Corcept Therapeutics (CORT) United States $7.347B 61.70
Stevanato Group S.p.A (STVN) IT $6.968B 41.09
Grifols, S.A (GRFS) Spain $6.855B 0.00
Ionis Pharmaceuticals (IONS) United States $6.796B 0.00
Ono Pharmaceutical (OPHLF) JP $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) US $3.596B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.003B 14.27
Crinetics Pharmaceuticals (CRNX) United States $2.919B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.709B 0.00
Hypermarcas (HYPMY) Brazil $2.686B 20.19
Procaps Group, S.A (PROCF) LU $2.557B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.520B 8.44
Centessa Pharmaceuticals (CNTA) United Kingdom $2.248B 0.00
Ocular Therapeutix (OCUL) United States $2.124B 0.00
Dyne Therapeutics (DYN) United States $1.919B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.744B 0.00
Guardian Pharmacy Services (GRDN) United States $1.673B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.578B 23.51
Ardelyx (ARDX) United States $1.533B 0.00
Harrow (HROW) United States $1.443B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.433B 0.00
Xeris Biopharma Holdings (XERS) US $1.264B 0.00
Evotec AG (EVO) Germany $1.243B 0.00
Collegium Pharmaceutical (COLL) United States $1.222B 6.68
Enliven Therapeutics (ELVN) United States $1.201B 0.00
ARS Pharmaceuticals (SPRY) US $1.148B 0.00
Cronos Group (CRON) Canada $0.996B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.836B 0.00
Akebia Therapeutics (AKBA) United States $0.833B 0.00
Elite Pharmaceuticals (ELTP) United States $0.735B 0.00
Theravance Biopharma (TBPH) US $0.699B 57.83
Rigel Pharmaceuticals (RIGL) US $0.697B 7.18
ProKidney (PROK) US $0.695B 0.00
KalVista Pharmaceuticals (KALV) United States $0.678B 0.00
Organogenesis (ORGO) US $0.653B 0.00
Relay Therapeutics (RLAY) US $0.619B 0.00
Tourmaline Bio (TRML) US $0.601B 0.00
Siga Technologies (SIGA) US $0.601B 7.42
USANA Health Sciences (USNA) US $0.583B 11.95
Xencor (XNCR) US $0.580B 0.00
Nektar Therapeutics (NKTR) United States $0.568B 0.00
Savara (SVRA) US $0.567B 0.00
Oruka Therapeutics (ORKA) US $0.554B 0.00
Zevra Therapeutics (ZVRA) US $0.509B 0.00
Esperion Therapeutics (ESPR) United States $0.448B 0.00
Nanobiotix S.A (NBTX) France $0.429B 0.00
Aquestive Therapeutics (AQST) United States $0.376B 0.00
Aldeyra Therapeutics (ALDX) United States $0.350B 0.00
Altimmune (ALT) United States $0.338B 0.00
Larimar Therapeutics (LRMR) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 19.37
4D Molecular Therapeutics (FDMT) United States $0.288B 0.00
Galectin Therapeutics (GALT) United States $0.274B 0.00
AleAnna (ANNA) United States $0.270B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.260B 0.00
Lexeo Therapeutics (LXEO) United States $0.259B 0.00
Korro Bio (KRRO) United States $0.217B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.214B 33.00
Lyell Immunopharma (LYEL) United States $0.213B 0.00
Aclaris Therapeutics (ACRS) United States $0.209B 0.00
Heron Therapeutics (HRTX) United States $0.207B 0.00
OmniAb (OABI) United States $0.196B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.169B 0.00
MEI Pharma (MEIP) United States $0.160B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Profound Medical (PROF) CA $0.134B 0.00
Inhibikase Therapeutics (IKT) United States $0.134B 0.00
Avalo Therapeutics (AVTX) United States $0.122B 0.00
Protara Therapeutics (TARA) US $0.120B 0.00
Avita Medical (RCEL) US $0.116B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.115B 0.00
Cassava Sciences (SAVA) US $0.110B 0.00
Surrozen (SRZN) US $0.104B 0.00
Wellgistics Health (WGRX) US $0.103B 0.00
Dominari Holdings (DOMH) United States $0.100B 0.00
Champions Oncology (CSBR) United States $0.094B 21.25
Cardiol Therapeutics (CRDL) Canada $0.090B 0.00
VAXART, INC (VXRT) US $0.089B 0.00
Assertio Holdings (ASRT) United States $0.080B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Pyxis Oncology (PYXS) US $0.079B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) US $0.074B 0.00
Unicycive Therapeutics (UNCY) US $0.074B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Gain Therapeutics (GANX) United States $0.072B 0.00
Liminatus Pharma (LIMN) United States $0.071B 0.00
Prelude Therapeutics (PRLD) US $0.068B 0.00
Vivani Medical (VANI) US $0.068B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Karyopharm Therapeutics (KPTI) United States $0.062B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.058B 0.00
PolyPid (PYPD) IL $0.053B 0.00
Verrica Pharmaceuticals (VRCA) US $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 31.73
Rafael Holdings (RFL) US $0.052B 0.00
Jupiter Neurosciences (JUNS) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
FibroGen (FGEN) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
Plus Therapeutics (PSTV) US $0.045B 0.00
Tempest Therapeutics (TPST) US $0.044B 0.00
Telomir Pharmaceuticals (TELO) US $0.043B 0.00
Klotho Neurosciences (KLTO) United States $0.043B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Relmada Therapeutics (RLMD) US $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) US $0.035B 0.00
Vivos Therapeutics (VVOS) US $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Mangoceuticals (MGRX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Scienture Holdings (SCNX) US $0.020B 0.00
Incannex Healthcare (IXHL) Australia $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Ainos (AIMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
TherapeuticsMD (TXMD) US $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ESSA Pharma (EPIX) Canada $0.011B 0.00
Phio Pharmaceuticals (PHIO) US $0.011B 0.00
Talphera (TLPH) US $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) US $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Heatwurx (PCSA) US $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
TNF Pharmaceuticals (TNFA) US $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) US $0.008B 0.00
TransCode Therapeutics (RNAZ) US $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.007B 0.00
Nuvilex (PMCB) US $0.006B 0.00
Vyome Holdings (HIND) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) US $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Salarius Pharmaceuticals (SLRX) US $0.003B 0.00
PainReform (PRFX) IL $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.002B 0.00
SciSparc (SPRC) IL $0.001B 0.00
Indivior (INDV) United States $0.000B 13.64
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.59
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00